Cargando…
Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
Autores principales: | Bennett, David, Cameli, Paolo, Lanzarone, Nicola, Carobene, Loredana, Bianchi, Nicola, Fui, Annalisa, Rizzi, Luigi, Bergantini, Laura, Cillis, Giuseppe, d’Alessandro, Miriana, Mazzei, Maria Antonietta, Refini, Rosa Metella, Sestini, Piersante, Bargagli, Elena, Rottoli, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990486/ https://www.ncbi.nlm.nih.gov/pubmed/31996217 http://dx.doi.org/10.1186/s12931-020-1303-8 |
Ejemplares similares
-
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020) -
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
por: Bergantini, Laura, et al.
Publicado: (2019) -
Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
por: d’Alessandro, Miriana, et al.
Publicado: (2021) -
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis
por: Refini, Rosa Metella, et al.
Publicado: (2020) -
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
por: Cameli, Paolo, et al.
Publicado: (2020)